Toggle navigation
About Us
Science & Innovation
Products and Resources
Our Responsibility
Careers
Investors
Media
Toggle navigation
Press Releases
Featured News
Press Statements
Subscribe
Media Contacts
Press Releases
Month Year
Su
Mo
Tu
We
Th
Fr
Sa
25
26
27
28
29
30
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1
2
3
4
5
Cancel
Go
Month Year
Su
Mo
Tu
We
Th
Fr
Sa
25
26
27
28
29
30
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1
2
3
4
5
Cancel
Go
Year
All Years
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
Category
All Categories
Corporate News
Product News
Vaccines News
Uncategorized
Keywords
Go
Advanced Search
Search
Search Headlines Only
Category
All Categories
Corporate News
Product News
Vaccines News
Uncategorized
From
To
Asset Types
Video
Audio
Photos
Documents
Events
Standard
Mar 24, 2005
Sanofi-aventis joins the fight against tuberculosis in South Africa
Mar 22, 2005
New Data Demonstrate Alvesco® (ciclesonide) Has a Low Incidence of Mouth- and Throat- Related Side Effects in Pediatric Asthma Patients
Mar 22, 2005
New Data Demonstrate Alvesco® (ciclesonide) Significantly Improves Quality-of-Life for Patients with Mild-to-Moderate Asthma
Mar 22, 2005
Court grants Sanofi-aventis's request for Order of Prohibition in the Canadian Plavix® litigation
Mar 11, 2005
SANOFI-AVENTIS SUES NOVOPHARM FOR PATENT INFRINGEMENT IN CANADA
Show
5
10
25
50
100
per page
«
1
…
178
179
180
181
182
183
184
185
186
»
Print
Email page
RSS